Medical Developments International Limited (ASX:MVP)
Australia · Delayed Price · Currency is AUD 0.4750
0.00 (0.00%)
Aug 21, 2026, 4:10 PM AEST
ASX:MVP Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 54 | 45 | 62 | 35 | 67 | 104 | |
Market Cap Growth | -25.20% | -28.18% | 77.27% | -47.74% | -35.75% | -67.54% |
Enterprise Value | 41 | 29 | 46 | 22 | 32 | 79 |
Last Close Price | 0.47 | 0.40 | 0.55 | 0.39 | 0.75 | 1.40 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 89.62 | 71.09 | 659.17 | - | - | - |
Forward PE | - | 65.83 | 22.54 | 208.39 | 208.39 | 208.39 |
PS Ratio | 1.26 | 1.05 | 1.59 | 1.05 | 2.07 | 4.74 |
PB Ratio | 0.96 | 0.80 | 1.12 | 0.76 | 0.82 | 1.82 |
P/TBV Ratio | 1.55 | 1.29 | 1.26 | 0.88 | 0.88 | 2.01 |
P/FCF Ratio | 10.16 | 8.45 | - | - | - | - |
P/OCF Ratio | 9.31 | 7.74 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.96 | 0.69 | 1.19 | 0.65 | 1.00 | 3.59 |
EV/EBITDA Ratio | 8.05 | 5.81 | 27.77 | - | - | - |
EV/EBIT Ratio | 17.10 | 12.35 | 329.69 | - | - | - |
EV/FCF Ratio | 7.75 | 5.59 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.03 | 0.05 |
Debt / EBITDA Ratio | 0.33 | 0.33 | 1.02 | - | - | - |
Debt / FCF Ratio | 0.32 | 0.32 | - | - | - | - |
Net Debt / Equity Ratio | -0.23 | -0.23 | -0.29 | -0.16 | -0.27 | -0.31 |
Net Debt / EBITDA Ratio | -2.50 | -2.50 | -9.47 | 0.60 | 1.39 | 1.55 |
Net Debt / FCF Ratio | -2.41 | -2.41 | 32.61 | 0.64 | 1.21 | 1.47 |
Asset Turnover | 0.65 | 0.65 | 0.62 | 0.41 | 0.33 | 0.23 |
Inventory Turnover | 1.45 | 1.45 | 1.06 | 1.02 | 1.31 | 1.05 |
Quick Ratio | 3.42 | 3.42 | 3.26 | 1.76 | 2.16 | 2.54 |
Current Ratio | 5.77 | 5.77 | 4.54 | 2.74 | 2.75 | 3.28 |
Return on Equity (ROE) | 1.13% | 1.13% | 0.19% | -64.53% | -8.09% | -19.76% |
Return on Assets (ROA) | 2.28% | 2.28% | 0.14% | -11.00% | -11.18% | -8.15% |
Return on Invested Capital (ROIC) | 5.54% | 5.79% | 0.20% | -28.96% | -34.98% | -33.55% |
Return on Capital Employed (ROCE) | 4.10% | 4.10% | 0.20% | -28.50% | -20.20% | -15.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 1.17% | 1.41% | 0.15% | -117.27% | -8.39% | -11.92% |
FCF Yield | 9.85% | 11.84% | -0.78% | -33.11% | -27.33% | -11.50% |
Buyback Yield / Dilution | -0.52% | -5.31% | -29.95% | -2.41% | -18.23% | -4.11% |
Total Shareholder Return | -0.52% | -5.31% | -29.95% | -2.41% | -18.23% | -4.11% |